SB
Simon Barry J.
Director
OFFICERM
Insider track record
ExecutiveAcross 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Simon Barry J., Director. Insider active across 1 company, notably ImmunityBio, Inc.. Aggregated, 13 disclosures have been logged. Split: 0 buy · 7 sells. Total volume traded: €2.8m. Activity tracked since 5 May 2021. The latest transaction was disclosed on 24 February 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations13 total
25,000 sharesCommon StockSEC:0001647994-26-000011:0
75,000 shares@ US$12.010525.9% of flowCommon StockSEC:0001647994-26-000006
75,000 shares@ US$12.01050.0091% mcap25.9% of flowCommon StockSEC:0001647994-26-000006:0
76,967 shares@ US$6.540.0052% mcap14.6% of flowCommon StockSEC:0001647994-26-000002:0
76,967 shares@ US$6.5414.6% of flowCommon StockSEC:0001647994-26-000002
15,243 shares0Common StockSEC:0001326110-25-000020:0
110,020 shares@ US$1.99846.7% of flowCommon StockSEC:0001326110-25-000006:0
57,200 shares0Common StockSEC:0001326110-24-000015:0
57,199 shares0Common StockSEC:0001326110-23-000113:0
14,990 shares@ US$16.08830.0024% mcap6.7% of flowCommon StockSEC:0001209191-21-035815:0
14,990 shares@ US$16.08836.7% of flowCommon StockSEC:0001209191-21-035815
56,967 shares@ US$1.75440.0010% mcap2.8% of flowCommon StockSEC:0001209191-21-030886:0
56,967 shares@ US$1.75442.8% of flowCommon StockSEC:0001209191-21-030886
About Simon Barry J.
Barry J. Simon is a Director at ImmunityBio, Inc. In this role, he participates in the governance of the company, contributing to strategic decision-making and oversight of operations. His expertise in the biopharmaceutical sector is valuable in guiding management and ensuring compliance with regulations. As a director, he plays a key role in developing the company's policies.